Target intelligence / Profile preview

SBDS pseudogene 1 (SBDSP1) (SBDSP1)

Target
SBDSP1
Molecular classification
pseudogene
01

Overview

SBDS pseudogene 1 (SBDSP1) is a non-functional copy of the chromosome 7 SBDS gene, sharing approximately 97% nucleotide sequence identity. SBDSP1 itself does not produce protein or have direct cellular functions. Its primary clinical relevance stems from gene conversion events with SBDS, which commonly result in pathogenic mutations leading to Shwachman-Diamond syndrome (SDS). These gene conversions account for most disease-causing SBDS mutations in SDS patients, complicating genetic diagnosis due to the pseudogene’s near-identical sequence. SBDSP1 is not a drug target, receptor, enzyme, or transporter and is not involved in molecular signaling, biological processes, or therapeutic interventions. SBDS (the *functional* gene) is a ribosome maturation factor with critical biological roles and is implicated in Shwachman-Diamond syndrome due to loss-of-function mutations. SBDSP1 (*the pseudogene*) is nearly identical at the sequence level but does not produce a functional protein and is not a therapeutic target.

Other names
SBDSPSBDS pseudogene 1ribosome assembly guanine nucleotide exchange factor pseudogene 1ribosome maturation factor pseudogene 1Shwachman-Bodian-Diamond syndrome pseudogene 1
02

Mechanism of action

None. SBDSP1 is not a therapeutic target; however, gene conversion with SBDSP1 leads to mutations in SBDS that cause Shwachman-Diamond syndrome

03

Biological functions

None (pseudogene)
04

Disease associations

Genetic contributor to Shwachman-Diamond syndrome via gene conversion
05

Safety considerations

None directly.Diagnostic challenges and potential misidentification of mutations due to high sequence similarity with functional SBDS can complicate genetic testing
06

Interacting drugs

None.
07

Biomarkers

None for direct targeting.However, mutations resulting from gene conversion events involving SBDSP1 are used as genetic biomarkers for Shwachman-Diamond syndrome in molecular diagnostics

Beyond the preview

Go deeper on SBDS pseudogene 1 (SBDSP1) (SBDSP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SBDS pseudogene 1 (SBDSP1) (SBDSP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call